Strong v. LifeStance Health Group Incorporated

District Court, D. Arizona·Decided October 6, 2025·No. 2:23-cv-00682·Unknown

Opinion

WO

Montana Strong, et al., No. CV-23-00682-PHX-KML

Plaintiffs, ORDER

v.

LifeStance Health Group Incorporated,

Defendant. Plaintiffs Montana Strong and Debra Yick filed this suit against LifeStance Health Group, Inc. (“LifeStance”) alleging federal and state claims based on tracking technology LifeStance allegedly used on its website. Jointly with LifeStance, plaintiffs now seek preliminary approval of a proposed class action settlement. (Doc. 79.) Because the proposed settlement contains concerning attorneys’ fees provisions, the present record does not allow for preliminary approval and the motion is denied without prejudice to renewal. I. Factual Background Defendant LifeStance is a mental healthcare company that offers “outpatient care services via in-person locations and telemedicine.” (Doc. 32 at 5.) LifeStance has 600 locations and “employs more than 5,200 psychiatrists, advance practice nurses, psychologists and therapists.” (Doc. 32 at 5.) Those professionals provide treatment for conditions including depression, PTSD, and bipolar disorder. (Doc. 32 at 23.) LifeStance markets and provides its services through a website, www.LifeStance.com. (Doc. 32 at 5.) Opting “to put its profits over the privacy of its Users, . . . LifeStance installed certain tracking technologies on its website in order to intercept and to send personally identifiable information (‘PII’) and protected health information (‘PHI’[)] . . . to third parties such as Meta Platforms, Inc. d/b/a Facebook . . . without the informed consent of its users.” (Doc. 32 at 6.) The tracking technology central to this case is known as the “Meta Pixel,” or simply “the Pixel.” II. Proposed Settlement Agreement Following this court’s January 2025 order denying in part LifeStance’s motion to dismiss, the parties discussed settlement and agreed to mediation after an exchange of informal discovery. (Doc. 79 at 12.) In April, the parties participated in a private, full-day mediation before the Hon. Suzanne H. Segal of Signature Resolution and subsequent remote sessions. (Doc. 79 at 12.) The parties ultimately agreed plaintiffs will resolve all claims related to the Pixel in exchange for LifeStance providing prospective class members a common fund and additional benefits described below. (Doc. 79 at 13.) Under the resulting proposed settlement agreement, the parties seek to certify for settlement purposes a class comprised of three subclasses:

1. Settlement Subclass 1: All members of LifeStance’s total patient population who booked at least one session through LifeStance’s online booking tool, accessed through LifeStance’s public website lifestance.com, between March 1, 2020 and April 30, 2023. 2. Settlement Subclass 2: All other members of LifeStance’s total patient population between March 1, 2020 and April 30, 2023, not including those in Settlement Subclass 1. 3. Settlement Subclass 3: All persons who visited the LifeStance website between March 1, 2020 and April 30, 2023 but did not book appointments online or otherwise become patients.

(Doc. 79 at 13.) The parties have identified 171,915 members of Subclass 1 and 907,737 members of Subclass 2. (Doc. 79 at 15.) Members of Subclass 1 will, upon timely submittal of a claim form, receive a pro rata cash payment from a LifeStance-funded non- reversionary fund of $1,203,405.00, less any amount the court awards for attorneys’ fees and costs. (Doc. 79 at 14.) Any unclaimed money will be sent to two data privacy organizations as cy pres recipients. (Doc. 79 at 25.) Members of Subclasses 1 and 2 will receive offers to enroll for free in a twelve-month subscription to a privacy monitoring service, which the parties value at approximately $265 per redemption. (Doc. 79 at 14.) Finally, all subclass members will receive injunctive relief: LifeStance will agree to “disable and forego use of all third-party tracking pixels, to the extent any remain, other than tracking pixels compliant with HIPAA, for a period of five (5) years from the Effective Date of this Settlement Agreement.” (Doc. 79 at 14). LifeStance maintains email address information for most members of Subclasses 1 and 2 and the parties have agreed to send notices via email (or postcards where emails bounce back). (Doc. 79 at 16, 27-28.) Because LifeStance does not maintain contact information for each person who accessed its website, the parties agreed to fund a media campaign directing members of Subclass 3 (and, necessarily, all class members) to the settlement website. (Doc. 79 at 28.) To cover these administrative costs, LifeStance agreed to separately create a $300,000 fund which will go to settlement administrator Angeion’s work delivering notice, maintaining the settlement website and toll-free hotline, evaluating claim forms, etc. (Doc. 79 at 15.) Finally, attorneys’ fees will be funded by two mechanisms. (Doc. 79 at 18.) The parties have agreed class attorneys will seek 25% or 33%1 plus litigation costs from the $1.2 million fund for attorneys’ fees attributable to plaintiffs’ counsel’s work securing the settlement for Subclass 1. (Doc. 79 at 18.) Separately, LifeStance will create a $750,000 fund for attorneys’ fees “attributable to the work done to secure the settlement benefits for Settlement Subclass 2 and Settlement Subclass 3.” (Doc. 79 at 15, 17-18.) LifeStance will not contest plaintiffs’ counsel requesting the $750,000 and any money from this fund which goes unawarded will revert to LifeStance. (Doc. 80-1 at 19.) In summary, the class settlement would provide the following. The 171,915 members of Subclass 1 would split approximately $800,000-$900,000 (i.e., $1,203,405.00

Free access — add to your briefcase to read the full text and ask questions with AI

Strong v. LifeStance Health Group Incorporated, (D. Ariz. 2025).

Strong v. LifeStance Health Group Incorporated (Strong v. LifeStance Health Group Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
In Re Bluetooth Headset Products Liability
654 F.3d 935 (Ninth Circuit, 2011)
Staton v. Boeing Co.
327 F.3d 938 (Ninth Circuit, 2003)
Ginger McCall v. Facebook, Inc.
696 F.3d 811 (Ninth Circuit, 2012)
Victor Parsons v. Charles Ryan
754 F.3d 657 (Ninth Circuit, 2014)
Theodore H. Frank v. Netflix, Inc.
779 F.3d 934 (Ninth Circuit, 2015)
Robert Briseno v. Conagra Foods, Inc.
998 F.3d 1014 (Ninth Circuit, 2021)
Hanlon v. Chrysler Corp.
150 F.3d 1011 (Ninth Circuit, 1998)
Vizcaino v. Microsoft Corp.
290 F.3d 1043 (Ninth Circuit, 2002)
Haralson v. U.S. Aviation Servs. Corp.
383 F. Supp. 3d 959 (N.D. California, 2019)
Alberto v. GMRI, Inc.
252 F.R.D. 652 (E.D. California, 2008)
Horton v. Usaa Casualty Insurance
266 F.R.D. 360 (D. Arizona, 2009)
Vinh Nguyen v. Radient Pharmaceuticals Corp.
287 F.R.D. 563 (C.D. California, 2012)